miorg.fi | Medical Immuno-Oncology Research Group – Unlocking the Potential of Immune Checkpoint Therapies to

Robots.txt Information

Robot	Path	Permission
GoogleBot	/	✔
BingBot	/	✔
BaiduSpider	/	✔
YandexBot	/	✔

Meta Tags

Title	Medical Immuno-Oncology Research Group – Unlocking the Potential of Immune Checkpoint Therapies to
Description	Medical Immuno-Oncology Research Group Unlocking the Potential of Immune Checkpoint Therapies to Treat Cold Tumors. Menu Home About Us Facilities Science
Keywords	N/A

Server Information

WebSite	miorg.fi
Host IP	130.232.246.230
Location	Finland

Related Websites

                        Site
                        Rank
                    

More to Explore

miorg.fi Valuation

US$270,691

Last updated: 2023-05-19 20:38:15

miorg.fi has Semrush global rank of 39,101,072. miorg.fi has an estimated worth of US$ 270,691, based on its estimated Ads revenue. miorg.fi receives approximately 31,234 unique visitors each day. Its web server is located in Finland, with IP address 130.232.246.230. According to SiteAdvisor, miorg.fi is safe to visit.

Traffic & Worth Estimates

Purchase/Sale Value	US$270,691
Daily Ads Revenue	US$250
Monthly Ads Revenue	US$7,497
Yearly Ads Revenue	US$89,953
Daily Unique Visitors	2,083
Note: All traffic and earnings values are estimates.

DNS Records

Host	Type	TTL	Data
miorg.fi.	A	7199	IP: 130.232.246.230
miorg.fi.	NS	86400	NS Record: ns-02.utu.fi.
miorg.fi.	NS	86400	NS Record: ns1.utu.fi.

HtmlToTextCheckTime:2023-05-19 20:38:15

Medical Immuno-Oncology Research Group Unlocking the Potential of Immune Checkpoint Therapies to Treat Cold Tumors. Menu Home About Us Facilities Science Academic Our Contributors Selected Publications Current open positions: Sponsors NEWS Contact Us Scroll down to content About Us Welcome to MIORG, an innovative immuno-oncology research group dedicated to revolutionizing cancer treatment by harnessing the power of the immune system. Our ultimate goal is to help patients overcome resistance to cutting-edge immunotherapies, leading to better treatment responses and improved quality of life. At the heart of our research strategy is a reverse translational approach. We begin by examining patient biopsies to uncover new biomarkers of resistance to immunotherapies. These invaluable biomarkers can serve as prognostic tools and targets for the development of novel adjuvant immunotherapies. We then meticulously validate the functions of these biomarkers in well-established in vivo and ex vivo

HTTP Headers

HTTP/1.1 301 Moved Permanently
Content-length: 0
Location: https://miorg.fi/

HTTP/1.1 200 OK
Date: Sat, 19 Nov 2022 09:01:58 GMT
X-Pingback: https://miorg.fi/xmlrpc.php
Link: ; rel="https://api.w.org/"
Link: ; rel="alternate"; type="application/json"
Link: ; rel=shortlink
Content-Type: text/html; charset=UTF-8
Strict-Transport-Security: max-age=31536000; includeSubDomains
X-Powered-By: Vapaan kansan lahja vapaalle tieteelle
Server: From a free people to free science and learning
X-XSS-Protection: 1; mode=block
X-Content-Type-Options: nosniff
X-Frame-Options: SAMEORIGIN
Set-Cookie: Variatio_Delectat=Claudius; path=/; HttpOnly; Secure

miorg.fi Whois Information

domain.............: miorg.fi
status.............: Registered
created............: 17.11.2020 15:24:49
expires............: 17.11.2026 15:24:49
available..........: 17.12.2026 15:24:49
modified...........: 17.11.2022 10:30:04
RegistryLock.......: no
Nameservers
nserver............: ns1.utu.fi [130.232.1.1] [OK]
nserver............: ns-02.utu.fi [130.232.252.112] [2001:708:220:20d::53] [OK]
DNSSEC
dnssec.............: no
Holder
name...............: Turun yliopisto
register number....: 0245896-3
address............: Yliopistonmaki
postal.............: 20014
city...............: Turun yliopisto
country............: Finland
Registrar
registrar..........: Gandi SAS
www................: www.gandi.net
>>> Last update of WHOIS database: 19.11.2022 11:02:46 (EET) <<<

miorg.fi valuation and analysis